Adventa Berhad in brief
Adventa Berhad is a listed company in the Healthcare sector, based in Malaysia. It was founded in 2004. Its last known market value was $25 M (January 2024); there is no current figure. Its shares trade under the symbol 7191.KL (Malaysia).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Adventa Berhad
Adventa Berhad (MYX: 7191) is a Malaysian holding company. It is headquartered in Petaling Jaya, Selangor, and is part of the Management of Companies and Enterprises Industry. It was founded in 2004. Adventa initially invested in the glove-making business. In 2012, the group divested the glove business to Aspion. The group then acquired Electron Beam and Lucenxia, which led them into the health care businesses. Their business also includes distribution and third-party logistics (3PL) for other health care companies.
In 2013, the group signed a partnership with Crawford Healthcare Limited, a United Kingdom healthcare company, to distribute the wound care products, Kerra™. The firm set up a new online portal, MyCare, selling healthcare and beauty products.
In 2014, the company will start its home renal dialysis service, which is known as the company's flagship business.
From Wikipedia: read the full article · text available under CC BY-SA 4.0
Adventa Berhad timeline
- 2004
- 🏁· approximateFounded
Events of Adventa Berhad from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in Malaysia: #157 (Jan 2022) · #302 (Jul 2023) · #302 (Jan 2024)
Peer comparison · Healthcare
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Adventa Berhad🇲🇾 | $25 M | — | — | — |
| Eli Lilly and Company🇺🇸 | $1.20 T | 43.4× | 31.9% | +44.7% |
| Johnson & Johnson🇺🇸 | $652.5 B | 40.5× | 16.2% | +6.0% |
| AbbVie Inc.🇺🇸 | $514.0 B | 49.7× | 15.7% | +8.6% |
| Roche Holding AG🇨🇭 | $370.3 B | 29.1× | 19.0% | — |
| UnitedHealth Group Incorporated🇺🇸 | $367.7 B | 23.1× | 3.5% | +11.8% |
| Merck & Co., Inc.🇺🇸 | $359.8 B | 146.7× | 3.6% | +1.3% |
| Novartis AG🇨🇭 | $286.8 B | 20.5× | 24.7% | — |
| Thermo Fisher Scientific Inc.🇺🇸 | $253.8 B | 35.9× | 14.9% | +3.9% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Questions people ask
Compare head to head
Similar companies by size and industry
- Eli Lilly and Company$1.20 T
- Johnson & Johnson$652.5 B
- AbbVie Inc.$514.0 B
- Roche Holding AG$370.3 B
- UnitedHealth Group Incorporated$367.7 B
- Merck & Co., Inc.$359.8 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 15, 2026
Figures from Wikidata, value.today research, Wikipedia.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Adventa Berhad? Verify and update this profile — free
Show Adventa Berhad's ranking or a chart on your website Get the badge
The badge updates itself as the ranking changes.